These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Biospecific haemosorbents based on proteinase inhibitor. I. Synthesis and properties. Platé NA; Valuev LI; Valueva TA; Chupov VV Biomaterials; 1993; 14(1):51-6. PubMed ID: 8425025 [TBL] [Abstract][Full Text] [Related]
4. [The use of a biospecific antiproteinase hemosorbent in the combined treatment of acute destructive pancreatitis]. Kirkovskiĭ VV; Antiperovich OF; Moin VM; Mazur LI; Lobacheva GA; Berezkina OG; Kushnirenko VS Vestn Khir Im I I Grek; 1994; 152(1-2):115-8. PubMed ID: 7701725 [TBL] [Abstract][Full Text] [Related]
5. [Effectiveness of the biospecific antiproteinase hemosorbent "Ovosorb" in the comprehensive treatment of diffuse suppurative peritonitis and acute destructive pancreatitis in dogs]. Filipovich NE; Kirkovskiĭ VV; Antiperovich OF; Sinilo SB; Lobacheva GA Patol Fiziol Eksp Ter; 1994; (1):47-9. PubMed ID: 8183598 [TBL] [Abstract][Full Text] [Related]
6. [Modified and immobilized preparations of basic polyvalent protease inhibitor for potential medical use]. Larionova NI; Kazanskaia NF; Mitiushina GV Vopr Med Khim; 1985; 31(4):25-30. PubMed ID: 2413623 [TBL] [Abstract][Full Text] [Related]
7. Biospecific haemosorbents based on proteinase inhibitor. III. Biospecific antiproteinase haemosorbent 'Ovosorb' in complex therapy of acute destructive pancreatitis. Kirkovsky VV; Antiperovich OF; Valueva TA; Moin VM; Lobacheva GA; Berezkina OG Biomaterials; 1994 Apr; 15(5):334-6. PubMed ID: 8061123 [TBL] [Abstract][Full Text] [Related]
8. [The effect of exogenous protein--a proteinase inhibitor--on the development of experimental pancreatitis in dogs]. Matveev NL; Valueva TA; Emel'ianov SI; Pisarevskiĭ GN; Titova GP; Penin VA; Mosolov VV Vopr Med Khim; 1990; 36(6):42-7. PubMed ID: 2075722 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the effectiveness of the use of specific hemosorption in acute experimental pancreatitis]. Ogloblina OG; Belova LA; Malakhov VN; Shtukaturov MIu; Brekhov EI Biull Eksp Biol Med; 1988 Oct; 106(10):430-3. PubMed ID: 3191230 [TBL] [Abstract][Full Text] [Related]
10. Biospecific haemosorbents based on proteinase inhibitor. II. Efficiency of biospecific antiproteinase haemosorbent 'Ovosorb' in complex treatment of experimental generalized purulent peritonitis and acute destructive pancreatitis in dogs. Platé NA; Kirkovsky VV; Antiperovich OF; Nicolaichik VV; Valueva TA; Sinilo SB; Moin VM; Lobacheva GA Biomaterials; 1994 Mar; 15(4):285-8. PubMed ID: 8031989 [TBL] [Abstract][Full Text] [Related]
11. [Dynamics of changes in the protease-inhibitory balance in blood plasma of dogs with experimental acute pancreatitis]. Belova LA; Privalov GV; Bazhenova GE; Shtukaturov MIu; Makarovskiĭ VV; Brekhov EI; Malakhov VN; Ogloblina OG Patol Fiziol Eksp Ter; 1991; (1):52-4. PubMed ID: 2057239 [TBL] [Abstract][Full Text] [Related]
15. Mucoadhesive polymers with immobilized proteinase inhibitors for oral administration of protein drugs. Plate NA; Valuev IL; Sytov GA; Valuev LI Biomaterials; 2002 Apr; 23(7):1673-7. PubMed ID: 11922470 [TBL] [Abstract][Full Text] [Related]
16. Covalent hybrids of ovomucoid third domains made from one synthetic and one natural peptide chain. Wieczorek M; Park SJ; Laskowski M Biochem Biophys Res Commun; 1987 Apr; 144(1):499-504. PubMed ID: 3555488 [TBL] [Abstract][Full Text] [Related]
17. Effects of protease inhibitors on coagulation abnormalities in acute canine pancreatitis. Izquierdo R; Sandberg L; Squillaci G; Hoppensteadt D; Walenga J; Fareed J; Prinz R Am Surg; 1984 Jun; 50(6):317-23. PubMed ID: 6203448 [TBL] [Abstract][Full Text] [Related]
18. [Experimental and clinical use of various forms of immobilized proteinases and their inhibitors]. Gostishchev VK; Tolstykh PI; Vasil'kova ZF; Vlasov LG; Virnik AD Vopr Med Khim; 1985; 31(4):21-4. PubMed ID: 3901511 [TBL] [Abstract][Full Text] [Related]
19. Acute pancreatitis in man. A clinical and biochemical study of pathophysiology and treatment. Lasson A Scand J Gastroenterol Suppl; 1984; 99():1-57. PubMed ID: 6205440 [TBL] [Abstract][Full Text] [Related]
20. [Potential clinical use of an acid-stable proteinase inhibitor from human urine]. Ogloblina OG; Belova LA; Malakhov VN; Parfenkova GA Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):40-4. PubMed ID: 2886138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]